Paroxetine vs.Clomipramine for Obsessive-compulsive Disorder:A Clinical Control Study
An Zhen
Abstract
An Zhen
Abstract
OBJECTIVE:To observe the curative effect and side effects of paroxetine vs.clomipramine in the treatment of obsessive-compulsive disorder.METHODS:60 patients with obsessive-compulsive disorder meeting the CCMD-3 diagnostic criteria were randomly assigned to receive either paroxetine or clomipramine for 8 weeks.YaleBrown Obsessive-compulsive Scale(Y-BOCS),Hamilton Depression Scale(HAMD),Hamilton Anxiety Scale(HAMA) and the clinical 4-grade criteria were used to evaluate the clinical efficacy;and the Treatment Emergent Symptom Scale(TESS) was employed to evaluate the side effects at study entry and at the end of weeks 4 and 8 of treatment.RESULTS:There was no significant difference in clinical efficacy between the two groups(P 0.05).Paroxetine showed significantly less side effects than did clomipramine(P 0.01) and good drug tolerability.CONCLUSION:Paroxetine is as effective as clomipramine yet with less daily dose,simple administration and less side effects in the treatment of obsessive-compulsive disorder.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To observe the curative effect and side effects of paroxetine vs.clomipramine in the treatment of obsessive-compulsive disorder.METHODS:60 patients with obsessive-compulsive disorder meeting the CCMD-3 diagnostic criteria were randomly assigned to receive either paroxetine or clomipramine for 8 weeks.YaleBrown Obsessive-compulsive Scale(Y-BOCS),Hamilton Depression Scale(HAMD),Hamilton Anxiety Scale(HAMA) and the clinical 4-grade criteria were used to evaluate the clinical efficacy;and the Treatment Emergent Symptom Scale(TESS) was employed to evaluate the side effects at study entry and at the end of weeks 4 and 8 of treatment.RESULTS:There was no significant difference in clinical efficacy between the two groups(P 0.05).Paroxetine showed significantly less side effects than did clomipramine(P 0.01) and good drug tolerability.CONCLUSION:Paroxetine is as effective as clomipramine yet with less daily dose,simple administration and less side effects in the treatment of obsessive-compulsive disorder.
Key concepts: Clomipramine, Paroxetine, Hamd, Tolerability, Obsessive compulsive, Psychology, Hamilton depression scale, Hypoactivity